BACKGROUND: Anemia is frequently encountered in critically ill patients and adversely affects cerebral oxygen delivery and brain tissue oxygen (PbtO2). The objective of this study is to assess whether there is an association between anemia and metabolic distress or brain tissue hypoxia in patients with subarachnoid hemorrhage. METHODS: Retrospective study was conducted in a neurological intensive care unit in a university hospital. Patients with subarachnoid hemorrhage that underwent multimodality monitoring with intracranial pressure, PbtO2 and microdialysis were analyzed. The relationships between hemoglobin (Hb) concentrations and brain tissue hypoxia (PbtO2 < or = 15 mmHg) and metabolic distress (lactate/pyruvate ratio > or =40) were analyzed with general linear models of logistic function for dichotomized outcomes utilizing generalized estimating equations. RESULTS: A total of 359 matched neuromonitoring hours and Hb measurements were analyzed from 34 consecutive patients. The median hemoglobin was 9.7 g/dl (interquartile range 8.8-10.5). After adjusting for significant covariates, reduced hemoglobin concentration was associated with a progressively increased risk of brain tissue hypoxia (adjusted OR 1.7 [1.1-2.4]; P = 0.01 for every unit decrease). Also after adjusting for significant covariates, hemoglobin concentrations below 9 g/dl and between 9.1 and 10 g/dl were associated with an increased risk of metabolic distress as compared to concentrations between 10.1 and 11 g/dl (adjusted OR 3.7 [1.5-9.4]; P = 0.004 for Hb < or = 9 g/dl and adjusted OR 1.9 [1.1-3.3]; P = 0.03 for Hb 9.1-10 g/dl). CONCLUSIONS: Anemia is associated with a progressively increased risk of cerebral metabolic distress and brain tissue hypoxia after subarachnoid hemorrhage.
BACKGROUND:Anemia is frequently encountered in critically illpatients and adversely affects cerebral oxygen delivery and brain tissue oxygen (PbtO2). The objective of this study is to assess whether there is an association between anemia and metabolic distress or brain tissue hypoxia in patients with subarachnoid hemorrhage. METHODS: Retrospective study was conducted in a neurological intensive care unit in a university hospital. Patients with subarachnoid hemorrhage that underwent multimodality monitoring with intracranial pressure, PbtO2 and microdialysis were analyzed. The relationships between hemoglobin (Hb) concentrations and brain tissue hypoxia (PbtO2 < or = 15 mmHg) and metabolic distress (lactate/pyruvate ratio > or =40) were analyzed with general linear models of logistic function for dichotomized outcomes utilizing generalized estimating equations. RESULTS: A total of 359 matched neuromonitoring hours and Hb measurements were analyzed from 34 consecutive patients. The median hemoglobin was 9.7 g/dl (interquartile range 8.8-10.5). After adjusting for significant covariates, reduced hemoglobin concentration was associated with a progressively increased risk of brain tissue hypoxia (adjusted OR 1.7 [1.1-2.4]; P = 0.01 for every unit decrease). Also after adjusting for significant covariates, hemoglobin concentrations below 9 g/dl and between 9.1 and 10 g/dl were associated with an increased risk of metabolic distress as compared to concentrations between 10.1 and 11 g/dl (adjusted OR 3.7 [1.5-9.4]; P = 0.004 for Hb < or = 9 g/dl and adjusted OR 1.9 [1.1-3.3]; P = 0.03 for Hb 9.1-10 g/dl). CONCLUSIONS:Anemia is associated with a progressively increased risk of cerebral metabolic distress and brain tissue hypoxia after subarachnoid hemorrhage.
Authors: Paul Vespa; Marvin Bergsneider; Nayoa Hattori; Hsiao-Ming Wu; Sung-Cheng Huang; Neil A Martin; Thomas C Glenn; David L McArthur; David A Hovda Journal: J Cereb Blood Flow Metab Date: 2005-06 Impact factor: 6.200
Authors: Mellanie V Springer; J Michael Schmidt; Katja E Wartenberg; Jennifer A Frontera; Neeraj Badjatia; Stephan A Mayer Journal: Neurosurgery Date: 2009-12 Impact factor: 4.654
Authors: Mauro Oddo; Andrew Milby; Isaac Chen; Suzanne Frangos; Eileen MacMurtrie; Eileen Maloney-Wilensky; Michael Stiefel; W Andrew Kofke; Joshua M Levine; Peter D Le Roux Journal: Stroke Date: 2009-03-05 Impact factor: 7.914
Authors: Gregory M T Hare; C David Mazer; James S Hutchison; Anya T McLaren; Elaine Liu; Alipasha Rassouli; Jinglu Ai; Rachel E Shaye; Julia A Lockwood; Cynthia E Hawkins; Nancy Sikich; Kevin To; Andrew J Baker Journal: J Appl Physiol (1985) Date: 2007-06-07
Authors: Howard L Corwin; Andrew Gettinger; Ronald G Pearl; Mitchell P Fink; Mitchell M Levy; Edward Abraham; Neil R MacIntyre; M Michael Shabot; Mei-Sheng Duh; Marc J Shapiro Journal: Crit Care Med Date: 2004-01 Impact factor: 7.598
Authors: Katja E Wartenberg; J Michael Schmidt; Jan Claassen; Richard E Temes; Jennifer A Frontera; Noeleen Ostapkovich; Augusto Parra; E Sander Connolly; Stephan A Mayer Journal: Crit Care Med Date: 2006-03 Impact factor: 7.598
Authors: Emir Festic; Alejandro A Rabinstein; William D Freeman; Elizabeth A Mauricio; Maisha T Robinson; Jay Mandrekar; Abba C Zubair; Augustine S Lee; Ognjen Gajic Journal: Neurocrit Care Date: 2013-04 Impact factor: 3.210
Authors: Pedro Kurtz; Raimund Helbok; Jan Claassen; J Michael Schmidt; Luis Fernandez; R Morgan Stuart; E Sander Connolly; Kiwon Lee; Stephan A Mayer; Neeraj Badjatia Journal: Neurocrit Care Date: 2016-02 Impact factor: 3.210
Authors: Ivan Rocha Ferreira Da Silva; Joao Antonio Gomes; Ari Wachsman; Gabriel Rodriguez de Freitas; Jose Javier Provencio Journal: J Crit Care Date: 2016-09-22 Impact factor: 3.425
Authors: Philippe Desjardins; Alexis F Turgeon; Marie-Hélène Tremblay; François Lauzier; Ryan Zarychanski; Amélie Boutin; Lynne Moore; Lauralyn A McIntyre; Shane W English; Andrea Rigamonti; Jacques Lacroix; Dean A Fergusson Journal: Crit Care Date: 2012-12-12 Impact factor: 9.097